Clinical Research Malaysia (CRM) – Dr. Mohamed Ali Abu Bakar, CEO
Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the…
Address: No. 43 2nd Floor, Jalan Mamanda 9, Ampang Point, 68000 Ampang, Selangor
,Malaysia
Tel: 603-4252 0278
Web: http://www.hospitals-malaysia.org/portal/index.asp
The Association of Private Hospitals of Malaysia
is more commonly known as APHM. This is an Association representing private hospitals and medical centers in Malaysia. The Association has been in existence since 1972 and currently has over 100 members throughout Malaysia.
APHM member hospitals are key partners with the public sector healthcare providers in bringing comprehensive medical care to all Malaysians through its member hospitals.
The APHM plays an important role in its objective of helping to raise standards of medical care within the country. Some of the activities geared towards this objective include :-
Working dialogues with public sector agencies including Ministry of Health Malaysia
Participation in National working groups such as MPC, MITI and MATRADE.
Training programs for all Healthcare providers which include the yearly Conference and Exhibition and regular smaller group workshops on clinical and administrative / managerial topics.
Promotion of Health Tourism Activities regionally and internationally with the Malaysia Healthcare Travel Council (MHTC)
Among various activities in which the association in involved, APHM promotes medical tourism. “Multi-ethnic, multi-cultural and multi-lingual Malaysia is an excellent choice for meeting your healthcare needs and medical concerns.” Also, it provides information about diseases and pandemia in frequent articles, such as « Management of Possible Avian Influenza in Private Healthcare Facilities », or « Information on Severe Acute Respiratory Syndrome (SARS) ».
Clinical Research Malaysia’s CEO discusses the need for Malaysia to focus on high quality pivotal trials rather than simply on a high number of trials. He shares with us the…
The National Heart Institute’s CEO portrays IJN as a national referral center for cardiovascular disease and declares: “IJN is equipped with the best in class technologies and is poised to…
“We believe the future lies with Universal health coverage and the formulation of one and only healthcare, with the merger of public and private sector under one reimbursement system” says…
PEMANDU’s Director for the Healthcare National Key Economic Area gives a thorough understanding of the various entry point projects that were implemented since 2010 to help Malaysia become a high…
Stefan Oschmann, President of the Emerging Markets at Merck and Co. described MSD as the dark horse of the emerging markets. How is MSD performing in Malaysia? Since the merger…
PhAMA was started in 1972 and now has most of the MNC players among its members which include 43 companies. How has the association evolved since its origin and what…
The pharmaceutical industry has been targeted as one of the key growth sectors for the Malaysian economy under the 10th Malaysia Plan, how successful in your opinion have the government…
Without a doubt, Malaysia shares all the major attributes of an emerging market, from the potential to expand market penetration to the increasing purchasing power of the population. So…
2011 marks the 10th anniversary of the company. Over that time you’ve enjoyed notable success including being the first Asian CRO to attain OECD GLP accreditation. Talk us through your…
Since its origin, Emerging Pharma has been helping foreign pharma companies to enter Malaysia. However, the Malaysian market is relatively small. Why should international pharma companies look to this country…
How would you describe the operating environment for foreign companies to use the services of Malaysian companies and how can you reassure these multinationals that sufficient intellectual property protection is…
Malaysia has good ethnic diversity, cost-effective infrastructure, and highly qualified principal investigators (PIs) and these elements have been in place for a long time. Why is now is the right…
See our Cookie Privacy Policy Here